Wolters Kluwer (WKL) - A Boring Dutch Compounder

I appreciate there’s been a number of posts on Wolters Kluwer (WKL) last 6 months, but it’s leaning towards one of my strongest conviction stocks so I thought I’d offer one further. DISCLOSURE: I hold shares and have a 22% return already, I just think it has a lot more to go. Wolters Kluwer is an Amsterdam listed information services business with what looks like a good quality setup. The AI angle also makes it a good debate. My core thesis is that WKL is a high quality subscription business that derated heavily on fears that AI would disintermediate professional information services, while every reported quarter since has shown the opposite, namely that WKL is monetising AI rather than being displaced by it. The share price fell from the €150s to the mid €50s across 2025 and early 2026. This looks like sentiment not evidence against its fundamentals. Business wise, if you are in the US you have probably never heard of them but your doctor likely uses UpToDate for clinical decisions, accountants run CCH, and bank compliance teams use their regulatory tools. Roughly 85% of revenue is recurring subscriptions. Their adjusted operating margins are approaching 29.4%, and the model compounds through mid single digit organic growth with steady margin expansion and consistent share cancellation. MOAT: The products are systems of record embedded in professional workflows where the cost of being wrong is severe. A doctor or tax professional does not want a probabilistic answer, they want a defensible, current, liability grade one, and that is what these subscriptions provide. Switching costs appear to be high, the content moats have taken decades to build, and importantly WKL is shipping its own AI products on top of that proprietary corpus. UpToDate Expert AI adoption keeps climbing and their agentic tax and legal tools are already deployed in hundreds of firms. The bear case assumes generic models replace curated professional content, and so far the customer behaviour is not showing this. ECONOMICS: The latest half year gave organic growth of 5% (6% if you strip the legacy print runoff), recurring revenues up 7%, cloud up 14%, margins up 100bps, constant currency EPS up 14%, FCF up 14%, guidance unchanged, and another 7.8m shares headed for cancellation. R&D is increasing up to 12 to 13% of revenue to fund the AI roadmap. Companies being disrupted don’t tend to print accelerating recurring revenue while expanding margins so all very positive. VALUATION: I ran a 20 year FCF model with a terminal value, aiming for a sensible base case. Price at time of writing: about €69 **Model output: about €100, so roughly a 32% discount** Inputs: FCF (millions): \~1,300 Net debt (millions): \~2,600 Discount rate: 9% Terminal growth: 2% Shares outstanding (millions): \~233 Growth: 7% years 1 to 5, 5% years 6 to 10, 2.5% years 11 to 20 For context, EPS and FCF are currently growing at 14% constant currency, so 7% fading to 5% shouldn’t be too aggressive at roughly half the current run rate. The output landing inside the sell side target cluster of €92 to €101 I take as a sanity check rather than validation, analysts and I are presumably staring at similar numbers. What the model says in plain terms is that today’s price only makes sense if growth roughly halves immediately and never recovers, which is a strange thing to price into a business whose recurring revenue just accelerated. I think the relative picture backs it up. WKL sits around 15 to 16x forward earnings while RELX and Thomson Reuters, same playbook with no better growth, trade in the mid 20s. Without any rerating you still collect low teens annual EPS growth plus a 3.7% dividend. The multiple normalising is the upside case, not the requirement. RISKS: I admit I’m holding this knowing the AI threat is unresolved rather than disproven. Renewal rates and recurring growth would be the best watch metrics if this is on your radar and you want more info. Also mid single digit organic growth means a stuck multiple could turn this into dead money with a sub 4% yield as consolation. And cheap European quality has stayed cheap before as we know. Finally the rising dev spend has to keep showing up as adoption, not just cost. Keen to hear pushback or criticism but thought I’d share my thoughts.